BEUDAMED
    11 results · 17ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters FDA Pre Market Approval × Classification: FDA Class 2 × Clear all

    System, Nuclear Magnetic Resonance Imaging

    FDA Pre-Market Approval
    FDA Class 2 ·GYROSCAN(TM)

    System, Nuclear Magnetic Resonance Imaging

    FDA Pre-Market Approval
    FDA Class 2 ·GYROSCAN(TM)

    System, Nuclear Magnetic Resonance Imaging

    FDA Pre-Market Approval
    FDA Class 2 ·GYROSCAN(TM)

    System, Nuclear Magnetic Resonance Imaging

    FDA Pre-Market Approval
    FDA Class 2 ·GYROSCAN(TM)

    System, Nuclear Magnetic Resonance Imaging

    FDA Pre-Market Approval
    FDA Class 2 ·GYROSCAN(TM)

    System, Nuclear Magnetic Resonance Imaging

    FDA Pre-Market Approval
    FDA Class 2 ·GYROSCAN(TM)

    System, Nuclear Magnetic Resonance Imaging

    FDA Pre-Market Approval
    FDA Class 2 ·GYROSCAN(TM)

    System, Test, Carcinoembryonic Antigen

    FDA Pre-Market Approval
    FDA Class 2 ·CEA-ROCHE TEST KIT

    System, Test, Carcinoembryonic Antigen

    FDA Pre-Market Approval
    FDA Class 2 ·CEA-ROCHE TEST KIT

    System, Test, Carcinoembryonic Antigen

    FDA Pre-Market Approval
    FDA Class 2 ·CEA-ROCHE TEST KIT

    System, Test, Carcinoembryonic Antigen

    FDA Pre-Market Approval
    FDA Class 2 ·CEA-ROCHE TEST KIT